BioCentury

7:00 AM GMT, May 30, 2016
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Clinical Results

Cabometyx cabozantinib: Phase II data

Top-line data from the open-label Phase II CABOSUN trial in 157 patients with previously untreated advanced RCC showed that first-line treatment with

Read the full 223 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.